Clinical trials: Time in Range
AF
Warfarin Quality, Adherence, Range, Determinants, and Events in Egyptian Rheumatic Heart Disease and Atrial Fibrillation
No Egyptian study has systematically quantified TTR, identified its predictors, or linked anticoagulation quality to clinical outcomes in the RHD-AF population.
- Trial name
- WARDEN-Egypt (NCT07826299)
- Testing
- INR, Time in Therapeutic Range, International Normalized Ratio (INR)
- Where
- Egypt
- Volunteers
- 90 people
- Sponsor
- Assiut University
Diabetes During Pregnancy
Fueling Labor: Protein Supplementation for Intrapartum Glucose Control
The goal of this study is to learn if high-protein drinks during labor can improve blood sugar control in pregnant women with insulin-treated diabetes.
- Trial name
- NCT07571343
- Testing
- High-Protein Beverage (Genius Gourmet Sparkling Protein Water), Standard Clear Liquid Diet, Continuous Glucose Monitoring (Abbott Freestyle Libre)
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Medical College of Wisconsin
Diabetes in Pregnancy
Effects of Moderate Carbohydrate Consumption on Metabolic and Obstetric Outcomes in Pregnant Women With Insulin-treated Diabetes- A Randomized Controlled Trial
Diabetes during pregnancy increases maternal and fetal complications, necessitating optimal glycemic control. The standard care diet (SCD, ≥175g/day carbohydrate) lacks robust evidence, particularly for pregnancies requiring…
- Trial name
- NCT06355154
- Testing
- Nutritional intervention
- Where
- Israel
- Volunteers
- 120 people
- Sponsor
- Hadassah Medical Organization
Type 2 Diabetes
Real-time Continuous Glucose Monitoring Compared With Intermittent Continuous Glucose Monitoring in People With Type 2 Diabetes Treated With Insulin.
The objective is to compare the efficacy of TR-CGM versus isCGM in patients diagnosed with T2D who are treated with insulin and use CGM, as defined by time in range between 70 and 180 mg/dL.
- Trial name
- NCT07308925
- Testing
- real time Continuous Glucose Monitoring
- Where
- Colombia
- Volunteers
- 108 people
- Sponsor
- Hospital Universitario San Ignacio
Gestational Diabetes
Time-in-range Using Continuous Glucose Monitoring Management of Gestational Diabetes Mellitus
The continual glucose is going to increase time-in-range compared to the standard method in women with gestational diabetes
- Trial name
- NCT04605497
- Testing
- Continuous glucose monitoring (CGM), Self-Capillary Blood Glucose Monitoring (SCBG)
- Where
- United States
- Volunteers
- 111 people
- Sponsor
- Oregon Health and Science University
Type1diabetes
The Current Health Status of Patients Living With Type 1 Diabetes From the LMC Diabetes Patient Registry
This retrospective study uses the Canadian LMC Diabetes Registry to describe the current health status of Canadians with type 1 diabetes.
- Trial name
- NCT04162067
- Where
- Canada
- Volunteers
- 3,600 people
- Sponsor
- LMC Diabetes & Endocrinology Ltd.
Atrial Fibrillation, Venous Thromboembolism
Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients
Warfarin is very effective for the prevention of blood clots (thrombosis). A test of coagulation, the prothrombin time (PT) is used to monitor the effect.
- Conditions
- Atrial Fibrillation, Venous Thromboembolism, Ischemic Stroke, Myocardial Infarction
- Trial name
- FORESPEAK-0 (NCT00814177)
- Testing
- warfarin
- Where
- Canada
- Volunteers
- 160 people
- Sponsor
- Hamilton Health Sciences Corporation
Diabetes Mellitus, Type 1
Assess the Impact of Insulclock on Glycemic Variability and Treatment Compliance in Uncontrolled DM1 Patients
Insulclock® is a small electronic device developed to facilitate the optimal administration of insulin. This device works as an add-on module of commercially available insulin pens and monitors the date, time and dose of…
- Trial name
- Segoclock2 (NCT04847778)
- Testing
- Use of Insulclock system, both Insulclock device and Insulclock 360 app., Use of Insulclock system, both Insulclock device and Insulclock app on masked mode.
- Where
- 4 sites in Spain
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Hospital General de Segovia
Pancreatitis, Acute, Hyperglycaemia
Glucose Levels in Acute Pancreatitis and the Impact of Insulin Depletion and Bacterial Endotoxaemia
There are currently no early predictive biomarkers for severity of acute pancreatitis (AP) that would allow stratification of patients for potential early interventional therapies.
- Trial name
- GLIDE (NCT06972238)
- Volunteers
- 30 people
- Sponsor
- Manchester University NHS Foundation Trust
Type 1 Diabetes, Type 1 Diabetes Mellitus With Hypoglycemia
Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes
Almost all people who have had type 1 diabetes for 5 years have a defect in secretion of the hormone Glucagon. This hormone is involved in the body's response to low blood glucose (hypoglycaemia).
- Conditions
- Type 1 Diabetes, Type 1 Diabetes Mellitus With Hypoglycemia, Hypoglycemia, Hypoglycemia Unawareness
- Trial name
- NCT04614168
- Testing
- Stepped hyperinsulinaemic-hypoglycaemic clamp study, Insulin pump, Continuous glucose monitor
- Where
- United Kingdom
- Volunteers
- 24 people
- Sponsor
- University of Edinburgh
Neck Pain, Neck Disability
This Study Explores How Short-term Immersive VR With Exercises and Ergonomic Training Can Reduce Neck Pain, Improve Movement, Strength, and Work Productivity in Computer Users Who Are at High Risk Due to Prolonged Screen Time and Poor Posture.
The goal of this clinical trial is to learn if a short-term immersive Virtual Reality (VR) intervention, combined with exercises and ergonomic training, can help treat neck pain in computer users.
- Conditions
- Neck Pain, Neck Disability, Neck Endurance, Work Productivity
- Trial name
- VR ROM (NCT06962982)
- Testing
- Therapeutic Exercises, Ergonomic Training, Human XR device - Oculus Quest 3
- Where
- United Arab Emirates
- Volunteers
- 30 people
- Sponsor
- Gulf Medical University
Type 2 Diabetes, End Stage Renal Disease on Dialysis
DIALYSIS-TIR Study
This study will look at control of blood sugar levels in persons with type 2 diabetes mellitus currently on chronic dialysis. Researchers will compare blood sugar levels in people taking semaglutide to people taking "dummy"…
- Trial name
- NCT06042153
- Testing
- Semaglutide
- Where
- 5 sites in United States
- Volunteers
- 43 people
- Sponsor
- University of Texas Southwestern Medical Center
Diabetes Mellitus, Diabetic Kidney Disease
Basal Plus GLP1-ra on Glycemic Variability in CKD
To compare GLP-1 RA plus basal insulin (BGLP) versus basal-bolus (BB) insulin regimens on glycemic variability (GV) and time in range (TIR) in diabetes patients CKD stage 3-4
- Trial name
- NCT05218915
- Testing
- Dulaglutide, Insulin Degludec, Continuous glucose monitor
- Where
- Hong Kong
- Volunteers
- 95 people
- Sponsor
- Elaine Chow
Muscle Fatigue
Electrical Stimulation vs. Static Stretching in the Leg Muscles
The retraction of the posterior leg muscles consists of a shortening of the muscle fibers that limits ankle dorsiflexion. The objective of this randomized controlled clinical trial (RCT) with a double-blind technique and…
- Trial name
- NCT06626698
- Testing
- Static stretching, Electrical muscle elongation
- Where
- Spain
- Volunteers
- 56 people
- Sponsor
- University of Seville
Diabetes Mellitus, Type 1
Is Real-time CGM Superior to Flash Glucose Monitoring
The aim of the investigator's study is to compare real-time continuous glucose monitoring and flash glucose monitoring in adult patients with Type 1 Diabetes during 4-day training program focused on physical activity and over 4…
- Trial name
- CORRIDA (NCT04358263)
- Testing
- Continuous Glucose Monitoring Guardian Connect Mobile system (real-time continuous glucose monitoring), Continuous Glucose Monitoring FreeStyle Libre Flash system (intermittently-scanned continuous glucose monitoring)
- Where
- Czechia
- Volunteers
- 60 people
- Sponsor
- Charles University, Czech Republic
Type 1 Diabetes, Diet Intervention
Effect of Different Carbohydrate Intake Patterns on Glycemic Control in Patients With Type 1 Diabetes
This multicenter, randomized, controlled, open-label clinical trial aims to evaluate the effects of different carbohydrate intake patterns on glycemic control in adults with type 1 diabetes.
- Conditions
- Type 1 Diabetes, Diet Intervention, Glucose Control
- Trial name
- NCT06273631
- Testing
- diverse carbohydrate diet, moderate carbohydrate diet
- Where
- China
- Volunteers
- 80 people
- Sponsor
- Yang Tao
Type 1 Diabetes, Obesity
ADJUnct Semaglutide Treatment in Type 1 Diabetes
The purpose of this study is to assess the use of once weekly semaglutide injection in inadequately controlled obese adults with type 1 diabetes (T1D) using FDA-approved hybrid closed-loop therapies.
- Trial name
- ADJUST-T1D (NCT05537233)
- Testing
- Semaglutide
- Where
- 4 sites in United States
- Volunteers
- 115 people
- Sponsor
- Viral N. Shah
Type 2 Diabetes, Obesity & Overweight
Influence of the Use of Specific Nutritional Formulas on Time in Range in Patients With Type 2 Diabetes
Who can participate? Individuals may be eligible to join this study if they meet the following criteria: Are 18 years or older. Have Type 2 diabetes with an A1c level higher than 7%.
- Conditions
- Type 2 Diabetes, Obesity & Overweight, Time in Range
- Trial name
- NCT07666581
- Testing
- Glucerna, Caloric restriction
- Where
- Colombia
- Volunteers
- 198 people
- Sponsor
- Hospital Universitario San Ignacio
Type 2 Diabetes
Long-Term Feedback Effect of FGM in Newly-Diagnosed T2D Patients
This clinical trial aims to evaluate the educational training of 12-weeks using flash glucose monitoring (FGM) FreeStyle Libre2 (FSL2; Abbott Diabetes Care Inc., Alameda, CA, USA) in newly- diagnosed T2D subjects who are treated…
- Trial name
- DIAFLASH (NCT06098040)
- Testing
- flash glucose monitoring continuous, capillary blood test, flash glucose monitoring intermittent
- Where
- Italy
- Volunteers
- 42 people
- Sponsor
- Campus Bio-Medico University
ICU, Dysglycemia
Glucose Time-In-Range Development Evaluation
The study will evaluate patients requiring frequent glucose monitoring in a Surgical ICU. The study population includes surgical critical care patients who require blood glucose monitoring.
- Trial name
- GIDE (NCT03670017)
- Testing
- OptiScanner® 5000 Glucose Monitoring System
- Where
- United States
- Volunteers
- 68 people
- Sponsor
- Washington University School of Medicine